Statistics
Publications
5
Citations
117
H-Index
5
Active since
2010
Xiangying Xia is an author at Sichuan University specializing in molecular oncology, proteomic tumor markers, and cancer biomarkers.
Publications per year
2010–2023
5
5
Preclinical characterization of tunlametinib, a novel, potent, and selective MEK inhibitor
Yahong Liu, Ying Cheng, Gongchao Huang et al. · Frontiers in Pharmacology · 2023 · 13 citations · Full text
Medicine, Oncology, Pharmacology +13
1–5 of 5